Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria

Ramanath Majumdar, Andrew Yori, Peggy W. Rush, Kimiyo Raymond, Dimitar Gavrilov, Silvia Tortorelli, Dietrich Matern, Piero Rinaldo, Gerald L. Feldman, Devin Oglesbee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Elevated plasma and urine formiminoglutamic acid (FIGLU) levels are commonly indicative of formiminoglutamic aciduria (OMIM #229100), a poorly understood autosomal recessive disorder of histidine and folate metabolism, resulting from formiminotransferase-cyclodeaminase (FTCD) deficiency, a bifunctional enzyme encoded by FTCD. Methods: In order to further understanding about the molecular alterations that contribute to FIGLU-uria, we sequenced FTCD in 20 individuals with putative FTCD deficiency and varying laboratory findings, including increased FIGLU excretion. Results: Individuals tested had biallelic loss-of-function variants in protein-coding regions of FTCD. The FTCD allelic spectrum comprised of 12 distinct variants including 5 missense alterations that replace conserved amino acid residues (c.223A>C, c.266A>G, c.319T>C, c.430G>A, c.514G>T), an in-frame deletion (c.1373_1375delTGG), with the remaining alterations predicted to affect mRNA processing/stability. These included two frameshift variants (c.990dup, c.1366dup) and four nonsense variants (c.337C>T, c.451A>T, c.763C>T, c.1607T>A). Conclusion: We observed additional FTCD alleles leading to urinary FIGLU elevations, and thus, providing molecular evidence of FTCD deficiency in cases identified by newborn screening or clinical biochemical genetic laboratory testing.

Original languageEnglish (US)
Pages (from-to)795-799
Number of pages5
JournalMolecular Genetics and Genomic Medicine
Volume5
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Formiminoglutamic Acid
Genes
Genetic Databases
Glutamate formiminotransferase deficiency
formiminotetrahydrofolate cyclodeaminase
RNA Stability
Genetic Testing
Folic Acid
Histidine
Open Reading Frames
Molecular Biology
Alleles
Urine
Amino Acids
Enzymes

Keywords

  • Formiminoglutamic acid
  • formiminotransferase-cyclodeaminase
  • inborn errors of metabolism

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology
  • Medicine(all)

Cite this

Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria. / Majumdar, Ramanath; Yori, Andrew; Rush, Peggy W.; Raymond, Kimiyo; Gavrilov, Dimitar; Tortorelli, Silvia; Matern, Dietrich; Rinaldo, Piero; Feldman, Gerald L.; Oglesbee, Devin.

In: Molecular Genetics and Genomic Medicine, Vol. 5, No. 6, 01.01.2017, p. 795-799.

Research output: Contribution to journalArticle

Majumdar, R, Yori, A, Rush, PW, Raymond, K, Gavrilov, D, Tortorelli, S, Matern, D, Rinaldo, P, Feldman, GL & Oglesbee, D 2017, 'Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria', Molecular Genetics and Genomic Medicine, vol. 5, no. 6, pp. 795-799. https://doi.org/10.1002/mgg3.333
Majumdar, Ramanath ; Yori, Andrew ; Rush, Peggy W. ; Raymond, Kimiyo ; Gavrilov, Dimitar ; Tortorelli, Silvia ; Matern, Dietrich ; Rinaldo, Piero ; Feldman, Gerald L. ; Oglesbee, Devin. / Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria. In: Molecular Genetics and Genomic Medicine. 2017 ; Vol. 5, No. 6. pp. 795-799.
@article{7ff5ad33755a4b9ba126cb85f34b842c,
title = "Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria",
abstract = "Background: Elevated plasma and urine formiminoglutamic acid (FIGLU) levels are commonly indicative of formiminoglutamic aciduria (OMIM #229100), a poorly understood autosomal recessive disorder of histidine and folate metabolism, resulting from formiminotransferase-cyclodeaminase (FTCD) deficiency, a bifunctional enzyme encoded by FTCD. Methods: In order to further understanding about the molecular alterations that contribute to FIGLU-uria, we sequenced FTCD in 20 individuals with putative FTCD deficiency and varying laboratory findings, including increased FIGLU excretion. Results: Individuals tested had biallelic loss-of-function variants in protein-coding regions of FTCD. The FTCD allelic spectrum comprised of 12 distinct variants including 5 missense alterations that replace conserved amino acid residues (c.223A>C, c.266A>G, c.319T>C, c.430G>A, c.514G>T), an in-frame deletion (c.1373_1375delTGG), with the remaining alterations predicted to affect mRNA processing/stability. These included two frameshift variants (c.990dup, c.1366dup) and four nonsense variants (c.337C>T, c.451A>T, c.763C>T, c.1607T>A). Conclusion: We observed additional FTCD alleles leading to urinary FIGLU elevations, and thus, providing molecular evidence of FTCD deficiency in cases identified by newborn screening or clinical biochemical genetic laboratory testing.",
keywords = "Formiminoglutamic acid, formiminotransferase-cyclodeaminase, inborn errors of metabolism",
author = "Ramanath Majumdar and Andrew Yori and Rush, {Peggy W.} and Kimiyo Raymond and Dimitar Gavrilov and Silvia Tortorelli and Dietrich Matern and Piero Rinaldo and Feldman, {Gerald L.} and Devin Oglesbee",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/mgg3.333",
language = "English (US)",
volume = "5",
pages = "795--799",
journal = "Molecular genetics & genomic medicine",
issn = "2324-9269",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Allelic spectrum of formiminotransferase-cyclodeaminase gene variants in individuals with formiminoglutamic aciduria

AU - Majumdar, Ramanath

AU - Yori, Andrew

AU - Rush, Peggy W.

AU - Raymond, Kimiyo

AU - Gavrilov, Dimitar

AU - Tortorelli, Silvia

AU - Matern, Dietrich

AU - Rinaldo, Piero

AU - Feldman, Gerald L.

AU - Oglesbee, Devin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: Elevated plasma and urine formiminoglutamic acid (FIGLU) levels are commonly indicative of formiminoglutamic aciduria (OMIM #229100), a poorly understood autosomal recessive disorder of histidine and folate metabolism, resulting from formiminotransferase-cyclodeaminase (FTCD) deficiency, a bifunctional enzyme encoded by FTCD. Methods: In order to further understanding about the molecular alterations that contribute to FIGLU-uria, we sequenced FTCD in 20 individuals with putative FTCD deficiency and varying laboratory findings, including increased FIGLU excretion. Results: Individuals tested had biallelic loss-of-function variants in protein-coding regions of FTCD. The FTCD allelic spectrum comprised of 12 distinct variants including 5 missense alterations that replace conserved amino acid residues (c.223A>C, c.266A>G, c.319T>C, c.430G>A, c.514G>T), an in-frame deletion (c.1373_1375delTGG), with the remaining alterations predicted to affect mRNA processing/stability. These included two frameshift variants (c.990dup, c.1366dup) and four nonsense variants (c.337C>T, c.451A>T, c.763C>T, c.1607T>A). Conclusion: We observed additional FTCD alleles leading to urinary FIGLU elevations, and thus, providing molecular evidence of FTCD deficiency in cases identified by newborn screening or clinical biochemical genetic laboratory testing.

AB - Background: Elevated plasma and urine formiminoglutamic acid (FIGLU) levels are commonly indicative of formiminoglutamic aciduria (OMIM #229100), a poorly understood autosomal recessive disorder of histidine and folate metabolism, resulting from formiminotransferase-cyclodeaminase (FTCD) deficiency, a bifunctional enzyme encoded by FTCD. Methods: In order to further understanding about the molecular alterations that contribute to FIGLU-uria, we sequenced FTCD in 20 individuals with putative FTCD deficiency and varying laboratory findings, including increased FIGLU excretion. Results: Individuals tested had biallelic loss-of-function variants in protein-coding regions of FTCD. The FTCD allelic spectrum comprised of 12 distinct variants including 5 missense alterations that replace conserved amino acid residues (c.223A>C, c.266A>G, c.319T>C, c.430G>A, c.514G>T), an in-frame deletion (c.1373_1375delTGG), with the remaining alterations predicted to affect mRNA processing/stability. These included two frameshift variants (c.990dup, c.1366dup) and four nonsense variants (c.337C>T, c.451A>T, c.763C>T, c.1607T>A). Conclusion: We observed additional FTCD alleles leading to urinary FIGLU elevations, and thus, providing molecular evidence of FTCD deficiency in cases identified by newborn screening or clinical biochemical genetic laboratory testing.

KW - Formiminoglutamic acid

KW - formiminotransferase-cyclodeaminase

KW - inborn errors of metabolism

UR - http://www.scopus.com/inward/record.url?scp=85040643638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040643638&partnerID=8YFLogxK

U2 - 10.1002/mgg3.333

DO - 10.1002/mgg3.333

M3 - Article

VL - 5

SP - 795

EP - 799

JO - Molecular genetics & genomic medicine

JF - Molecular genetics & genomic medicine

SN - 2324-9269

IS - 6

ER -